Cantitate/Preț
Produs

Linking Neuroscience and Behavior in COVID-19

Editat de Rajkumar Rajendram, Victor R. Preedy, Vinood Patel, Colin R Martin
en Limba Engleză Hardback – 19 iul 2024
Linking Neuroscience and Behavior in COVID-19 examines the effect of both the virus and the pandemic on behavior and mental health. Chapters look at the burden of the COVID-19 pandemic on those with pre-existing conditions, including Parkinson’s disease and multiple sclerosis. The ongoing consequences of the pandemic on the mental health of the broad populace are discussed. As well as the neurological effects of the virus itself, chapters discuss psychological concerns including depression and anxiety. Finally, the chapters also include aspects relevant to managing care and the treatment of conditions. A broad range of conditions preceding, caused by, or emerging for the first time during the pandemic are also detailed.

  • Discusses the impact of the COVID-19 pandemic and the virus itself on behavior and psychology
  • Examines comorbidities including Parkinson’s disease, neuroinflammation, and autism spectrum disorders
  • Outlines the management and care for coexisting conditions including brain tumors, multiple sclerosis, and ischemic stroke
  • Features chapters on the severe damage to the nervous system which may be caused by SARS-CoV-2 infection including myelitis
  • Contains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and procedures
Citește tot Restrânge

Preț: 114528 lei

Preț vechi: 125854 lei
-9% Nou

Puncte Express: 1718

Preț estimativ în valută:
21925 23899$ 18436£

Carte disponibilă

Livrare economică 20 noiembrie-04 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323956505
ISBN-10: 0323956505
Pagini: 630
Dimensiuni: 216 x 276 mm
Editura: ELSEVIER SCIENCE

Cuprins

Section A: Introductory chapters and setting the scene
1. The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic
Taslima Nasrin, Md Samim Hassan, Arijit Samanta, Mehboob Hoque, and Safdar Ali
2. Different variants of SARS-CoV-2
Arijit Samanta, Md Samim Hassan, Taslima Nasrin, Syed Sahajada Mahafujul Alam, Zarnain Jamil, Harpal S. Buttar, Safdar Ali, and Mehboob Hoque
3. Lateral flow assay for SARS-CoV-2 infection: Uses and limitations
Mirajul Islam, Taslima Nasrin, Arijit Samanta, Safdar Ali, Harpal S. Buttar, and Mehboob Hoque
4. Linking community participation, mobility disabilities, and the COVID-19 pandemic
Kara B. Ayers, Jean P. Hall, and Claire Burdick
5. Influence of the sources used to obtain information on COVID-19 and their impact on mental health
Juan Gómez-Salgado, Juan Jesús García-Iglesias, Regina Allande-Cussó, and Carlos Ruiz-Frutos

Section B: Impact on behavior and psychology
6. The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors
Amy Pascoe, Karen Willis, and Natasha Smallwood
7. Impact of COVID-19 on behavior in autism spectrum disorder
Giulia Antolini and Marco Colizzi
8. Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond
Xiangfei Meng
9. Compulsive hoarding in the COVID-19 pandemic
Nicole Loren Angelo, Andrea Pozza, Debora Rossi, Ilaria Aicardi, Giulia Chieppa, Isabella Bove, Federica Ragucci, Francesco Iocca, Daniele Pugi, and Donatella Marazziti
10. The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic
Sayo Hamatani, Anton K€all, Konomi Shoda, and Kazuki Matsumoto
11. The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceived
stress
Joana Bücker, Adriane Ribeiro Rosa, and Letícia Sanguinetti Czepielewski
12. The Covid-19 pandemic and the occupational overload of health professionals: Indicators of
burnout
Isabella Lara Machado Silveira, Flávia de Lima Osório, and Sonia Regina Loureiro
13. Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications
Mohammad Nazmus Sakib
14. Acute neurocognitive disorder as a presenting manifestation of COVID-19
Brad Tyson, Leigh Tyson, Sudeshna Ray, and Pinky Agarwal
15. Mental health and the impact of confinement
Lorabi Souhib, David Sánchez-Teruel, Selma Boufellous, and María Auxiliadora Robles-Bello
16. Cannabis use in the COVID-19 pandemic: Changes in different populations and implications
for policy
Adam Zaweel, Isaac Kuk, Soyeon Kim, Bernard Le Foll, and Christine M. Wickens
17. Impact of COVID-19 on mental health in women: Socioeconomic groups and global aspects
Khushi Kumar, Aashni Udani, and Maushmi S. Kumar
18. Quality of life assessment of patients after COVID-19
Eleni Tsimitrea, Paraskevi Siamouti, Konstntinos I. Gourgoulianis, and Evangelos C. Fradelos
19. COVID-19 pandemic and remote working: Toward a new way of working
Ferdinando Toscano and Teresa Galanti
20. Long COVID and its persistence: A focus on mental health
Michael John Dwyer, Massimo Mirandola, and Elda Righi
21. The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of life
Kubra Yeni

Section C: Effects on neurological structures and mechanisms
23. Linking pediatric COVID-19 with basal ganglia and dentate nucleus
Shraddha Sunthwal, Sagar Lad, and Preeti Lad
24. Sensory disorders, neuroinflammation, and COVID-19
Pietro De Luca and Arianna Di Stadio
25. The effects of COVID-19 isolations on nonmotor features of Parkinson’s disease
Santangelo Gabriella and Carmine Vitale
26. Myelitis following COVID-19: The road so far
Cristiana Silva and Sónia Batista
27. The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine
Luca Procaccini and Antonio Bernardini
28. Assessing the impact of prenatal SARS-CoV-2 exposure on infants’ neurodevelopment: A comprehensive analysis of current evidence
Fernanda Nava and Vania Aldrete-Cortez
29. Electroencephalographic features with COVID-19
Isabel M. Sáez-Landete, Adriana Gómez-Domínguez, Beatriz Estrella-León, and Alba Díaz-Cid
30. Survivors of COVID-19 and clinical neuropsychological domain characteristics
Pamela E. May-Weeks and Vaishali Phatak
31. Neuroinflammation following SARS-CoV-2 infection
Carlos Alexandre Netto and Marimelia A Porcionatto
32. Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-19
Giulia Cattarinussi, Alessandro Miola, and Fabio Sambataro
33. Impact of COVID-19 on the brain: Antibodies against brain stem antigens
Guglielmo Lucchese, Antje Vogelgesang, Angela Stufano, and Agnes Flöel
34. The kynurenine pathway and role in mental health of post-COVID-19 patients
Melike Kucukkarapinar, Filiz Karadag, and Selcuk Candansayar

Section D: Management, support and treatments
35. Management of brain tumors in the COVID-19 pandemic
Rajesh Balakrishnan, Sharief K. Sidhique, Patricia Sebastian, and Selvamani Backianathan
36. The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase
Irene Scala, Simone Bellavia, Aldobrando Broccolini, Giovanni Frisullo, Pier Andrea Rizzo, Eleonora Rollo, Giacomo Della Marca, and Valerio Brunetti
37. Long COVID and the potential use of palmitoylethanolamide
Rocco Salvatore Calabro` and Loredana Raciti
38. Cognitive assessments in post-COVID syndrome: A focus on the neuropsychological tests and
protocols
Cristina Delgado-Alonso and Jordi A. Matias-Guiu
39. Supporting individuals with intellectual and developmental disabilities during the COVID-19
pandemic
David Ervin, Melody Jan, Emily J. Johnson, Lin Peters, and Carl Tyler
40. Preserving well-being and quality of life through school-based interventions focused on physical
activity during the COVID-19 pandemic
Alice Masini, Francesco Sanmarchi, and Laura Dallolio
41. Hesitancy in using COVID 19 prevention behaviors among African Americans: Strategies to
build confidence
Jennifer Cunningham Erves, Jamaine Davis, Elizabeth C. Stewart, Vanessa B. Crowther, and Whitney George
42. New strategies for psychological well-being at work
Teresa Galanti and Ferdinando Toscano
43. Mitigating mental health changes with virtual reality technology during Covid-19: A narrative
Muhammad Hizri Hatta, Chong Siew Koon, and Suriati Mohamed Saini
44. Music therapy for patients with neurological disorders during COVID-19 pandemic
Claudia Vinciguerra, Salvatore Iacono, Vincenzo Di Stefano, Valerio Nardone, and Antonio Federico
45. Mental health and the modulating effects of receiving the COVID-19 vaccination
Natsu Sasaki and Norito Kawakami
46. Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic
Riccardo Dalle Grave, Anna Dalle Grave, and Simona Calugi
47. Social anxiety disorder and Covid 19: Treatment with cognitive behavioral therapy
Narendra Nath Samantaray and Sapam Kiran Dolly
48. Burnout during the COVID-19 pandemic: Modulating role of mindfulness
Makiko Sampei and Naho Morisaki

Section E: Case studies with mini review
49. Case study: Evaluation of a long Covid assessment service (LCAS)
Colin R. Martin, Scarlett Maloney, Sarah Fowler, Frances Farnworth, Katie Tyrrell, and Abigail Webb
50. Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic
Roula Markoulakis and Anthony Levitt
51. Case study: Restless leg syndrome associated with COVID-19
Cyprian Popescu

Section F: Resources
52. Recommended resources for linking neuroscience and behavior in coronavirus disease
(COVID-19)
Rajkumar Rajendram, Daniel Gyamfi, Vinood B. Patel, and Victor R. Preedy